Compare MXL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | PLSE |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2009 | 2015 |
| Metric | MXL | PLSE |
|---|---|---|
| Price | $22.03 | $19.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $19.80 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 930.5K | 226.8K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $478,596,000.00 | N/A |
| Revenue This Year | $22.10 | $840.00 |
| Revenue Next Year | $10.70 | $287.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.08 | $12.56 |
| 52 Week High | $21.63 | $26.30 |
| Indicator | MXL | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 73.61 | 45.72 |
| Support Level | $15.97 | $13.62 |
| Resistance Level | N/A | $20.40 |
| Average True Range (ATR) | 0.87 | 1.52 |
| MACD | 0.51 | -0.32 |
| Stochastic Oscillator | 100.00 | 29.27 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.